This is the authors' abstract. We don't add key points for this paper.
In situ polymerized gel polymer electrolytes (GPEs) offer a promising route to improve electrode–electrolyte interfacial compatibility in quasi-solid-state lithium metal batteries. Although LiClO4 has been employed in such systems, its role beyond a lithium-ion source has not been systematically investigated. Here, we report a two-component electrolyte consisting of 1 M LiClO4 and 0.3 M BF3-THF (1-0.3PTHF) that enables the in situ formation of poly(tetrahydrofuran) (PTHF) with substantially reduced initiator loading. The incorporation of LiClO4 not only provides mobile Li+ ions but also facilitates polymerization. Possible ionic interactions between LiClO4 species and growing polymer chains may contribute to the improvement. The 1-0.3PTHF exhibited a narrow mass distribution (Đ = 1.23) and a low degree of crystallinity (4.7%) compared to commercial PTHF (Đ = 3.25) and the PTHF polymerized without LiClO4. The in situ 1-0.3PTHF delivered a bulk ionic conductivity of 2.75 × 10−3 S cm−1, an electrochemical window of 5.06 V, and stable lithium plating/stripping up to 3 mA cm−2, suggesting its promise as a GPE. Post-mortem XPS confirms the coexistence of B-containing species and LiCl within the SEI. Full cell tests demonstrated the preliminary feasibility of the 1-0.3PTHF GPE with LFP, LCO, and NCM cathodes. This work highlights the multifunctional role of LiClO4 in in situ polymerized PTHF. The resulting 1-0.3PTHF electrolyte simultaneously regulates polymerization, enhances ionic conduction, and promotes protective SEI formation. These findings broaden the role of lithium salts beyond lithium-ion sources to polymerization modulators in in situ polymerized GPEs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: